As we count down to the 60th STS Annual Meeting, here’s a sneak peek at some engaging presentations featuring cutting-edge research and challenging cases you won’t want to miss.
Age-Stratified Surgical Aortic Valve Replacement for Aortic Stenosis: An Analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database
Speaker: Christopher Mehta, MD
Saturday, January 27, 9:45 - 11:15 a.m.
This talk will show how the analysis of trusted data in the STS National Database helps inform multidisciplinary heart teams to decide between surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) for patients. Attendees will gain insight into how the national landscape for SAVR and TAVR changed between 2011 and 2022, and how current aortic valve guidelines for TAVR and SAVR, if not followed, could be risky, especially for younger patients.
A Comprehensive Approach to the Management of Patients with HLHS and HLHS-Related Malformation
Speaker: Mark S. Bleiweis, MD
Saturday, January 27, 9:45 - 11:15 a.m.
This presentation focuses on a comprehensive approach to maximizing survival and optimizing the utilization of donor hearts in patients with HLHS and HLHS-related malformations with functionally univentricular ductal-dependent circulation. And while VAD support can stabilize these patients and minimize mortality due to prolonged times on the waitlist, primary cardiac transplantation offers the best option for the survival of neonates.
A Mediation Analysis of Anemia and Transfusions with CABG Outcomes in the National STS Database
Speaker: Motahar Hosseini, MD
Saturday, January 27, 1:15 - 2:45 p.m.
Utilization of national STS data of more than 53,000 patients who underwent CABG in 2019 features prominently in this session comparing operative mortality and outcomes of patients who presented with preoperative anemia to those who were non-anemic at baseline. This discussion will highlight the potential importance of treating preoperative anemia to reduce intraoperative RBC transfusions to help improve outcomes after CABG.
Guidelines versus Practice: A Statewide Survival Analysis of SAVR versus TAVR in Patients Aged <60 Years
Speaker: Jad Malas, MD
Sunday, January 28, 8:15 - 9:45 a.m.
The outcomes of using transcatheter versus surgical management to treat aortic valve disease in young adults will be examined in this compelling discussion. By utilizing eight years of data and analyzing practice paradigm trends and shifts over the study period, attendees will learn why we should advocate for considering a surgical approach in younger aortic stenosis patients.
Hospital Volume Does Not Mitigate the Effect of Community Socioeconomic Deprivation on Outcomes of Heart Transplantation
Speaker: Sara Sakowitz, MS, MPH
Sunday, January 28, 8:15 - 9:45 a.m.
A focus on how socioeconomic disadvantage is associated with inferior patient survival following heart transplantation will take center stage during this presentation. A detailed examination of how future efforts, and, ultimately, national policy changes, are needed to improve longitudinal follow-up care and address systemic barriers to necessary health care will also be discussed.
Chemoimmunotherapy versus Adjuvant Chemoimmunotherapy for Stage IB-IIIA Non-Small Cell Lung Cancer
Speaker: Russell Seth Martins, MBBS
Sunday, January 28, 8:15 - 9:45 a.m.
Presenters will provide details on a study which compares the use of neoadjuvant chemoimmunotherapy versus adjuvant chemoimmunotherapy for surgically resectable clinical stage IB to IIIA non-small cell lung cancer (NSCLC), using the National Cancer Database. The session will highlight the role immunotherapy plays in the understanding of overall survival benefits in the neoadjuvant/adjuvant settings.
Burden of Reoperative Cardiac Surgery among Adolescents and Adults Who Have Undergone Prior Arterial Switch Operation (ASO): Society of Thoracic Surgeons Database Analysis
Speaker: Bret Mettler, MD
Sunday, January 28, 2:30 - 4 p.m.
This session will unveil findings on increased survival rates for adolescents and adults who have undergone arterial switch operations (ASO), as well as the potential for these patients to require cardiac reoperations to address arterial switch-related complications that arise later in life. Also included will be the results of the largest multi-study of post-ASO reoperations beyond early childhood, and how they add to current knowledge regarding procedural prevalence, categories, and trends – including implications for pre-operative surgical counseling and post-operative clinical surveillance.
Automated New World: AI Changing the Future of Cardiothoracic Surgery
Speaker: Tom C. Nguyen, MD
Sunday, January 28, 2:30 - 4 p.m.
This highly interactive session will take a close look at what is – and isn't – AI. And perhaps more importantly, how AI will radically change medicine and CT surgery and will be the most disruptive technology to date. The discussion will be a primer for those who are both experts and new to AI. Attendees should be ready for a lively and fun presentation.
Managing the Cyanotic Neonate with Tetralogy of Fallot: Primary Repair, Surgical Shunt, or Transcatheter Stent? A Decision Analysis
Speaker: Samuel Hoenig
Sunday, January 28, 4:30 - 6 p.m.
Details on decision tree microsimulation models constructed to simulate morbidity, mortality, and healthcare costs for a synthetic cohort of cyanotic TF neonates eligible for early primary repair will be among the topics covered in this talk. An examination of why primary repair is the preferred treatment for these patients – over staged stenting and shunting – resulting in superior postoperative morbidity and mortality outcomes, as well as cost-utility, will be outlined.
Predictors of Venous Thromboembolism after Pulmonary Resection for Lung Cancer – An Analysis of the STS General Thoracic Surgery Database
Speaker: Andrea Axtell, MD
Monday, January 29, 1:15 - 2:45 p.m.
Given the wide variability in the reported rates of postoperative venous thromboembolism (VTE), this talk will explore the incidence and outcomes of clinically recognized postoperative VTE after lung cancer resection using the STS General Thoracic Surgery Database. Session attendees will gain insight into important risk factors predictive of postoperative VTE and VTE-associated mortality, which improve the safety of lung cancer resection. Attendees will also learn how high-risk groups may benefit from enhanced perioperative prophylactic measures.